Paul J Harrison Selected Research

metabotropic glutamate receptor 3 (mGluR3)

12/2017	A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding.
11/2016	Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
12/2011	Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition.
11/2008	Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.
10/2008	Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Harrison Research Topics

Disease

48	Schizophrenia (Dementia Praecox) 11/2021 - 09/2002
15	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2004
10	Mental Disorders (Mental Disorder) 01/2021 - 01/2004
6	Psychotic Disorders (Schizoaffective Disorder) 09/2022 - 07/2006
5	COVID-19 01/2022 - 01/2021
5	Mood Disorders (Mood Disorder) 01/2019 - 07/2002
4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 05/2015
4	Paranoid Disorders (Paranoia) 10/2017 - 03/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 11/2003
3	Neurodevelopmental Disorders 10/2017 - 09/2003
2	Dementia (Dementias) 09/2022 - 01/2021
2	Sleep Wake Disorders 09/2022 - 01/2022
2	Delirium 01/2021 - 01/2020
2	Glioma (Gliomas) 06/2010 - 06/2002
2	Starvation 06/2008 - 06/2000
2	Weight Gain 04/2005 - 04/2004
1	Alopecia (Baldness) 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Infections 01/2022
1	Venous Thromboembolism 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Treatment-Resistant Depressive Disorder 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Human Influenza (Influenza) 09/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021
1	Stroke (Strokes) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Shellfish Poisoning 01/2018
1	Hallucinations (Hallucination) 10/2017
1	Autistic Disorder (Autism) 01/2017
1	Intellectual Disability (Idiocy) 01/2017

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 10/2014 - 09/2002
10	Protein Isoforms (Isoforms)IBA 12/2017 - 04/2005
9	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 10/2017 - 04/2005
6	Pharmaceutical PreparationsIBA 01/2021 - 02/2015
6	AntibodiesIBA 01/2020 - 11/2016
6	Neuregulin-1 (Neuregulin 1)IBA 03/2018 - 04/2006
5	Glutamic Acid (Glutamate)FDA Link 11/2021 - 06/2002
5	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 06/2002
5	metabotropic glutamate receptor 3 (mGluR3)IBA 12/2017 - 10/2008
4	LithiumIBA 01/2022 - 01/2016
4	Biological ProductsIBA 01/2020 - 07/2002
4	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2018 - 09/2007
4	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 09/2002
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2015 - 02/2008
3	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 09/2013
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2020
3	Calcium Channels (Calcium Channel)IBA 02/2019 - 01/2016
3	Serine (L-Serine)FDA Link 10/2014 - 09/2007
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2008 - 02/2004
2	Pregabalin (Lyrica)FDA Link 01/2022 - 01/2017
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 01/2017
2	AMPA Receptors (AMPA Receptor)IBA 11/2021 - 01/2018
2	AcidsIBA 11/2021 - 01/2018
2	DiureticsIBA 01/2021 - 01/2020
2	CalciumIBA 01/2021 - 06/2002
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 01/2020
2	Dihydrotachysterol (AT 10)IBA 10/2017 - 05/2015
2	Complement System Proteins (Complement)IBA 01/2017 - 03/2012
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2017 - 11/2003
2	Dronabinol (THC)FDA LinkGeneric 11/2015 - 03/2015
2	NeuregulinsIBA 07/2012 - 02/2003
2	metabotropic glutamate receptor 2IBA 12/2011 - 11/2008
2	EnzymesIBA 01/2011 - 09/2007
2	netrin-G1IBA 06/2010 - 03/2008
2	serine racemaseIBA 06/2010 - 09/2007
2	CalcineurinIBA 12/2005 - 04/2005
2	5-HT2C Serotonin ReceptorIBA 04/2005 - 04/2004
1	Angiotensin Receptor AntagonistsIBA 09/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	mRNA VaccinesIBA 09/2021
1	Ad26COVS1IBA 09/2021
1	ChAdOx1 nCoV-19IBA 09/2021
1	VaccinesIBA 09/2021
1	Clostridium perfringens epsilon-toxinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Thrombin FDA Link 01/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 02/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2018
1	Clozapine (Clozaril)FDA LinkGeneric 01/2018
1	Aluminum Oxide (Sapphire)IBA 01/2018
1	titanium dioxide (Titania)FDA Link 01/2018
1	Zinc Oxide FDA Link 01/2018
1	LigandsIBA 12/2017
1	eglumetadIBA 01/2017

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2019